ADAM17 substrate release in proximal tubule drives kidney fibrosis
- PMID: 27642633
- PMCID: PMC5026414
- DOI: 10.1172/jci.insight.87023
ADAM17 substrate release in proximal tubule drives kidney fibrosis
Abstract
Kidney fibrosis following kidney injury is an unresolved health problem and causes significant morbidity and mortality worldwide. In a study into its molecular mechanism, we identified essential causative features. Acute or chronic kidney injury causes sustained elevation of a disintegrin and metalloprotease 17 (ADAM17); of its cleavage-activated proligand substrates, in particular of pro-TNFα and the EGFR ligand amphiregulin (pro-AREG); and of the substrates' receptors. As a consequence, EGFR is persistently activated and triggers the synthesis and release of proinflammatory and profibrotic factors, resulting in macrophage/neutrophil ingress and fibrosis. ADAM17 hypomorphic mice, specific ADAM17 inhibitor-treated WT mice, or mice with inducible KO of ADAM17 in proximal tubule (Slc34a1-Cre) were significantly protected against these effects. In vitro, in proximal tubule cells, we show that AREG has unique profibrotic actions that are potentiated by TNFα-induced AREG cleavage. In vivo, in acute kidney injury (AKI) and chronic kidney disease (CKD, fibrosis) patients, soluble AREG is indeed highly upregulated in human urine, and both ADAM17 and AREG expression show strong positive correlation with fibrosis markers in related kidney biopsies. Our results indicate that targeting of the ADAM17 pathway represents a therapeutic target for human kidney fibrosis.
Conflict of interest statement
The authors have declared that no conflict of interest exists.
Figures









Similar articles
-
Proximal Tubule-Derived Amphiregulin Amplifies and Integrates Profibrotic EGF Receptor Signals in Kidney Fibrosis.J Am Soc Nephrol. 2019 Dec;30(12):2370-2383. doi: 10.1681/ASN.2019030321. Epub 2019 Nov 1. J Am Soc Nephrol. 2019. PMID: 31676723 Free PMC article.
-
Extracellular oxidation in cystic fibrosis airway epithelium causes enhanced EGFR/ADAM17 activity.Am J Physiol Lung Cell Mol Physiol. 2018 Apr 1;314(4):L555-L568. doi: 10.1152/ajplung.00458.2017. Epub 2017 Dec 14. Am J Physiol Lung Cell Mol Physiol. 2018. PMID: 29351448
-
KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury.Am J Physiol Renal Physiol. 2021 Aug 1;321(2):F135-F148. doi: 10.1152/ajprenal.00127.2021. Epub 2021 Jun 21. Am J Physiol Renal Physiol. 2021. PMID: 34151589 Free PMC article.
-
Role of ADAM17 in kidney disease.Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F333-F342. doi: 10.1152/ajprenal.00625.2018. Epub 2019 May 29. Am J Physiol Renal Physiol. 2019. PMID: 31141400 Review.
-
The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.Mediators Inflamm. 2018 Jan 9;2018:1067134. doi: 10.1155/2018/1067134. eCollection 2018. Mediators Inflamm. 2018. PMID: 29540993 Free PMC article. Review.
Cited by
-
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.Front Pharmacol. 2024 Aug 21;15:1394997. doi: 10.3389/fphar.2024.1394997. eCollection 2024. Front Pharmacol. 2024. PMID: 39234105 Free PMC article. Review.
-
Acute Kidney Injury-Induced Circulating TNFR1/2 Elevations Correlate with Persistent Kidney Injury and Progression to Fibrosis.Cells. 2023 Sep 5;12(18):2214. doi: 10.3390/cells12182214. Cells. 2023. PMID: 37759437 Free PMC article.
-
ADAMs family in kidney physiology and pathology.EBioMedicine. 2021 Oct;72:103628. doi: 10.1016/j.ebiom.2021.103628. Epub 2021 Oct 12. EBioMedicine. 2021. PMID: 34653870 Free PMC article. Review.
-
The Role of the EGF Receptor in Sex Differences in Kidney Injury.J Am Soc Nephrol. 2019 Sep;30(9):1659-1673. doi: 10.1681/ASN.2018121244. Epub 2019 Jul 10. J Am Soc Nephrol. 2019. PMID: 31292196 Free PMC article.
-
MicroRNA-708-3p as a potential therapeutic target via the ADAM17-GATA/STAT3 axis in idiopathic pulmonary fibrosis.Exp Mol Med. 2018 Mar 30;50(3):e465. doi: 10.1038/emm.2017.311. Exp Mol Med. 2018. PMID: 29869625 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous